Skip to main content
. 2022 Feb 3;17:69. doi: 10.1186/s13018-022-02968-y

Table 2.

Comparison of the Hepple stage 2 and stage 3 patients of the lesion group

Variable Hepple stage 2 group (n = 32) Hepple stage 3 group (n = 28) Pa value
Age 32.38 ± 8.88 34.75 ± 7.73 0.277b
BMI 24.62 ± 2.49 24.81 ± 3.13 0.792b
VAS 6.03 ± 2.01 6.14 ± 1.11 0.795b
AOFAS 70.22 ± 9.15 69.14 ± 9.57 0.658b
KAFS 66.03 ± 8.11 66.86 ± 9.23 0.713b
ATT 7.41 ± 1.78 7.43 ± 1.85 0.962b
Disease duration, mo 15.72 ± 3.24 16.61 ± 3.21 0.291b

BMI, Body mass index; VAS, Visual Analogue Scale; AOFAS, American Orthopaedic Foot and Ankle Society; KAFS, Karlsson Ankle Function Score; ATT, Anterior Talar Translation

aA value p < 0.05 was set as statistically significant

bt test